SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 151 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2017. The put-call ratio across all filers is 1.99 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $0 | -100.0% | 2,000 | -50.0% | 0.00% | -100.0% |
| Q3 2018 | $7,000 | 0.0% | 4,000 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $7,000 | 0.0% | 4,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $7,000 | -22.2% | 4,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $9,000 | -25.0% | 4,000 | 0.0% | 0.00% | -25.0% |
| Q3 2017 | $12,000 | -33.3% | 4,000 | 0.0% | 0.00% | -33.3% |
| Q2 2017 | $18,000 | -5.3% | 4,000 | 0.0% | 0.01% | -14.3% |
| Q1 2017 | $19,000 | -20.8% | 4,000 | 0.0% | 0.01% | -36.4% |
| Q4 2016 | $24,000 | +9.1% | 4,000 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $22,000 | +46.7% | 4,000 | 0.0% | 0.01% | +37.5% |
| Q2 2016 | $15,000 | +150.0% | 4,000 | +100.0% | 0.01% | +166.7% |
| Q1 2016 | $6,000 | -45.5% | 2,000 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $11,000 | 0.0% | 2,000 | 0.0% | 0.01% | -14.3% |
| Q3 2015 | $11,000 | -35.3% | 2,000 | 0.0% | 0.01% | -30.0% |
| Q2 2015 | $17,000 | +88.9% | 2,000 | 0.0% | 0.01% | +100.0% |
| Q1 2015 | $9,000 | – | 2,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,009,984 | $16,683,000 | 6.50% |
| DAFNA Capital Management LLC | 317,563 | $2,636,000 | 2.23% |
| Trellus Management Company, LLC | 162,900 | $1,352,000 | 1.53% |
| PURA VIDA INVESTMENTS, LLC | 246,250 | $2,246,000 | 1.15% |
| WALL STREET ASSOCIATES | 861,200 | $7,148,000 | 0.67% |
| EAM Investors, LLC | 670,346 | $5,564,000 | 0.65% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 200,000 | $1,660,000 | 0.58% |
| CARL DOMINO INC | 66,900 | $555,000 | 0.38% |
| Belmont Global Advisors, Inc. | 36,200 | $300,000 | 0.33% |
| Lombard Odier Asset Management (USA) Corp | 507,223 | $4,210,000 | 0.30% |